Synapse Medicine

Synapse Medicine, founded in 2017, is a promising player in the Health Care sector, focusing on transforming medication management through advanced technology. Headquartered in France, the company seeks to achieve "Medication Success with Clinical Decision Support."

Their innovative approach utilizes a comprehensive global knowledge base driven by sophisticated algorithms, offering a SaaS platform designed for effective prescription and medication management throughout the patient journey. By partnering with leading hospitals and digital health companies across the United States, Europe, and Japan, Synapse aims to set new standards in medication regimens.

Synapse Medicine's growth trajectory is reinforced by a significant €25.00M Series B investment received in March 2022 from prominent investors such as XAnge, BNP Paribas Developpement, Korelya Capital, MACSF, and Mutuelles Impact. This funding supports their mission to solidify their innovation-driven position in the Medical Devices and Pharmaceutical industries.